MAP2K7 and lung cancer: TRAF1 seems to serve as a ‘break’ for TRAF2 driving BRAF degradation, which activates MEK and ERK mediation of lung cancer cell growth, apoptosis or lung tumorigenesis [89] (Fig. 1).